Insider trading

Period: 120 months Stock: MDT Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

44 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

44 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

44 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

44 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
44 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
44 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

44 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
19 Feb 2026
KIIL HARRY SKIP EVP & President Cardiovascular
Sold at will 5×
$5.13M 52,524 at 97.71
61.6%
Sold half or more
19 Nov 2025
Smith Gregory L EVP Global Ops & Supply Chain
Sold at will 7×
$3.06M 30,000 at 101.95
39.5%
Not planned
24 Jan 2025
Wall Brett A. EVP & Pres Neuroscience
Sold on a plan
$1.12M 12,437 at 90.00
23.3%
Planned (10b5-1)
7 Jun 2024
Martha Geoffrey Chairman and CEO
Sold at will 2×
$1.60M 19,113 at 83.77
11.8%
Not planned
21 Feb 2024
Salmon Sean EVP & President Cardiovascular
Sold at will 3×
$2.61M 30,695 at 85.13
38.9%
Not planned
13 Dec 2022
Salmon Sean EVP & President Cardiovascular
Sold, plan not stated
$1.34M 16,631 at 80.50
31.5%
30 Sep 2021
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$6.22M 49,147 at 126.58
50.2%
Sold half or more
31 Aug 2021
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$6.81M 50,775 at 134.17
51.0%
Sold half or more
25 Aug 2021
Salmon Sean EVP & Pres Diabetes/Cardiovasc
Sold, plan not stated 2×
$3.81M 28,419 at 134.08
46.0%
25 Aug 2021
Sold, plan not stated 2×
$1.54M 11,581 at 132.67
10.8%
28 Jun 2021
Sold, plan not stated
$1.44M 11,500 at 125.29
12.3%
28 May 2021
Liddicoat John R EVP & President of Americas
Sold, plan not stated
$4.39M 34,656 at 126.65
44.9%
5 Apr 2021
Sold, plan not stated 2×
$1.39M 11,712 at 118.83
12.5%
28 Dec 2020
Surface Carol A SVP, Chief HR Officer
Sold, plan not stated
$1.72M 15,000 at 114.90
30.5%
18 Dec 2020
WHITE ROBERT JOHN EVP & Pres. Medical Surgical
Sold, plan not stated
$1.26M 10,930 at 115.46
19.6%
9 Nov 2020
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$2.34M 20,715 at 113.13
27.7%
8 Oct 2020
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated 2×
$2.28M 20,714 at 110.00
27.6%
9 Sep 2020
TEN HOEDT ROB EVP & President EMEA
Sold, plan not stated
$1.00M 9,563 at 105.05
15.3%
24 Dec 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated 5×
$5.78M 50,856 at 113.58
41.7%
2 Dec 2019
WHITE ROBERT JOHN EVP & President MITG
Sold, plan not stated 4×
$5.77M 52,166 at 110.62
50.0%
Sold half or more
15 Nov 2019
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated 3×
$4.10M 36,874 at 111.25
16.4%
1 Nov 2019
WHITE ROBERT JOHN EVP & President MITG
Sold, plan not stated 5×
$5.70M 52,165 at 109.33
50.0%
Sold half or more
1 Nov 2019
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated 2×
$4.27M 38,976 at 109.50
17.2%
27 Sep 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated 2×
$2.30M 21,425 at 107.51
21.4%
10 Sep 2019
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated 9×
$8.89M 82,877 at 107.31
72.9%
Sold half or more
12 Jun 2019
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated 2×
$5.13M 52,664 at 97.49
55.2%
Sold half or more
6 Jun 2019
Martha Geoffrey EVP & GroupPres Restora Therap
Sold, plan not stated
$1.06M 11,000 at 96.05
18.4%
24 May 2019
Bought
$1.01M 10,900 at 92.40
13.8%
First buy on file
9 Jan 2019
ISHRAK OMAR Chairman & CEO
Bought
$1.01M 12,000 at 84.05
2.1%
First buy on file
24 Sep 2018
Martha Geoffrey EVP & GroupPres Restora Therap
Sold, plan not stated
$4.88M 49,799 at 97.93
45.7%
31 Aug 2018
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$2.52M 26,159 at 96.29
29.5%
28 Aug 2018
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$4.52M 47,176 at 95.88
30.9%
22 Aug 2018
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated
$13.90M 145,544 at 95.50
42.1%
8 Jun 2018
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$1.00M 11,500 at 87.13
9.8%
9 Jan 2018
Kuntz Richard SrVP & Chief Scien, Clin, Reg
Sold, plan not stated
$6.77M 78,526 at 86.21
40.1%
5 Jan 2018
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$2.22M 26,158 at 85.00
28.4%
15 Dec 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.33M 16,000 at 82.82
15.3%
16 Nov 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.26M 16,000 at 79.02
12.8%
16 Oct 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.25M 16,000 at 78.03
11.4%
15 Sep 2017
ISHRAK OMAR Chairman & CEO
Sold, plan not stated
$11.46M 140,407 at 81.63
21.0%
17 Jul 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.06M 12,000 at 88.57
8.1%
20 Mar 2017
TEN HOEDT ROB EVP & President EMEA
Sold, plan not stated
$4.14M 50,757 at 81.58
49.8%
15 Mar 2017
ISHRAK OMAR Chairman & CEO
Sold, plan not stated
$7.87M 95,000 at 82.82
14.7%
2 Mar 2017
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$4.31M 52,316 at 82.33
47.0%
Showing 1–44 of 44.